{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:49:32Z","timestamp":1792511372509,"version":"4.5.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04251-6","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T03:33:21Z","timestamp":1770262401000},"page":"3445-3450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Longitudinal analysis of systemic inflammatory biomarkers in glioblastoma patients: an exploratory single\u2011center analysis"],"prefix":"10.1007","volume":"28","author":[{"given":"Yener","family":"\u015eahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"\u015eenses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Erdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Sakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1320-9105","authenticated-orcid":false,"given":"Beste Melek","family":"Atasoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"1","key":"4251_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neucir.2020.11.005","volume":"33","author":"O Alan","year":"2022","unstructured":"Alan O, Telli TA, Baso\u011flu T, Arikan R, Demircan NC, Ercelep O, et al. Impact of prognostic nutritional index on survival in recurrent glioblastoma. Neurocirugia. 2022;33(1):15\u201321.","journal-title":"Neurocirugia"},{"issue":"1","key":"4251_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11060-023-04357-9","volume":"164","author":"L Gurrieri","year":"2023","unstructured":"Gurrieri L, Mercatali L, Ibrahim T, Fausti V, Dall\u2019Agata M, Riva N, et al. Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series. J NeuroOncol. 2023;164(1):55\u201364.","journal-title":"J NeuroOncol"},{"issue":"16","key":"4251_CR3","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.3390\/cancers13164226","volume":"13","author":"AS Basheer","year":"2021","unstructured":"Basheer AS, Abas F, Othman I, Naidu R. Role of inflammatory mediators, macrophages, and neutrophils in glioma maintenance and progression: mechanistic understanding and potential therapeutic applications. Cancers. 2021;13(16):4226.","journal-title":"Cancers"},{"issue":"13","key":"4251_CR4","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.3390\/cancers15133339","volume":"15","author":"P Jarmuzek","year":"2023","unstructured":"Jarmuzek P, Kozlowska K, Defort P, Kot M, Zembron-Lacny A. Prognostic values of systemic inflammatory immunological markers in glioblastoma: a systematic review and meta-analysis. Cancers. 2023;15(13):3339.","journal-title":"Cancers"},{"issue":"1","key":"4251_CR5","doi-asserted-by":"publisher","first-page":"2415401","DOI":"10.1080\/07853890.2024.2415401","volume":"56","author":"Z Wu","year":"2024","unstructured":"Wu Z, Cao Y, Liu Z, Geng N, Pan W, Zhu Y, et al. Study on the predictive value of laboratory inflammatory markers and blood count-derived inflammatory markers for disease severity and prognosis in COVID-19 patients: a study conducted at a university-affiliated infectious disease hospital. Ann Med. 2024;56(1):2415401.","journal-title":"Ann Med"},{"issue":"5","key":"4251_CR6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3390\/biomedicines12051067","volume":"12","author":"JM Gon\u00e7alves","year":"2024","unstructured":"Gon\u00e7alves JM, Carvalho B, Tuna R, Pol\u00f3nia P, Linhares P. Sequential evaluation of hematology markers as a prognostic factor in glioblastoma patients. Biomedicines. 2024;12(5):1067.","journal-title":"Biomedicines"},{"key":"4251_CR7","doi-asserted-by":"publisher","first-page":"e893","DOI":"10.1016\/j.wneu.2024.02.148","volume":"185","author":"E Bayatli","year":"2024","unstructured":"Bayatli E, Ozgural O, Dogan I, Ozpiskin OM, Hasimoglu S, Kuzukiran YC, et al. Prediction of meningioma grade using hematological parameters. World Neurosurg. 2024;185:e893\u20139.","journal-title":"World Neurosurg"},{"issue":"1","key":"4251_CR8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12894-023-01379-3","volume":"23","author":"R Wu","year":"2023","unstructured":"Wu R, Hu M, Zhang P. Predictive value of systematic immune-inflammation index combined with Ki-67 index on prognosis of prostate cancer patients after laparoscopic radical prostatectomy. BMC Urol. 2023;23(1):210.","journal-title":"BMC Urol"},{"issue":"1","key":"4251_CR9","doi-asserted-by":"publisher","first-page":"vdaf014","DOI":"10.1093\/noajnl\/vdaf014","volume":"7","author":"AH Mohammad","year":"2025","unstructured":"Mohammad AH, Sakalla R, Davalan W, Ruiz-Barerra MA, Jatana S, Khalaf R, et al. Rise in post-resection neutrophil-to-lymphocyte ratio correlates with decreased survival in glioblastoma patients. Neuro-Oncol Adv. 2025;7(1):vdaf014.","journal-title":"Neuro-Oncol Adv"},{"key":"4251_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61030376","author":"S Lee","year":"2025","unstructured":"Lee S, Kim M. Analysis of patients with glioblastoma treated with standard 6-week chemoradiation followed by temozolomide: treatment outcomes and prognostic factors. Medicina Kaunas. 2025. https:\/\/doi.org\/10.3390\/medicina61030376.","journal-title":"Medicina Kaunas"},{"issue":"5","key":"4251_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, Van Den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459\u201366. https:\/\/doi.org\/10.1016\/S1470-2045(09)70025-7.","journal-title":"Lancet Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04251-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04251-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04251-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:29:18Z","timestamp":1784975358000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04251-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":11,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["4251"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04251-6","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"15 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study (reference number 09.2024.1002) was approved by the Marmara University School of Medicine Noninterventional Ethics Committee on September 20, 2024, to analyze and publish data from patients who completed treatment and follow-up.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Human ethics and consent to participate declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data will be made available on request from corresponding author","order":4,"name":"Ethics","label":"Data availability","group":{"name":"EthicsHeading","label":"Declarations"}}]}}